1 / 39

Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn. Chronic Disease - what happens when they come in multiples? Susan Smith. Overview: Multimorbidity. Background Why important Impact Research programme Policy and healthcare delivery.

nemesio-lazaro
Download Presentation

Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Royal College of Surgeons in IrelandColáiste Ríoga na Máinleá in Éirinn Chronic Disease - what happens when they come in multiples? Susan Smith

  2. Overview: Multimorbidity • Background • Why important • Impact • Research programme • Policy and healthcare delivery

  3. Academic general practice grounded in clinical practice Chronic disease research: How can we improve outcomes? • Organisational approaches • DiSC, Sphere studies • Patient oriented interventions • Family diabetes study, Peer support study • Multimorbidity

  4. Clinical case • 59 year old woman • Living alone • IHD; Depression; Neurological condition; Arthritis • Multiple medications • Presents with pain in her right shoulder

  5. Clinical Reality “Just remember Dr Marshall, my life is like a swimming pool full of sewage and your job is to push me up into the shallow end.” Martin Marshall, McKenzie Lecture, 2010

  6. Multimorbidity • Two or more chronic conditions • Ireland: • 66%, aged > 50, in GP setting • Not just older people • MM aged 45-64, GMS eligible: 7.5 meds; 11 GP visits per year

  7. Impact • Higher rates mortality, medicines use, health service use, hospital admissions, psychological problems such as depression and anxiety • Poorer quality of life and physical functioning

  8. Impact: costs • Costs in Ireland five times higher for patients with four or more conditions. Have average: • 11 GP visits per year • 3 OPD visits • 3.5 admissions • Reducing costs: • ‘Million dollar patients’ Cost savings?? • Reducing avoidable complications for people with chronic disease by 10% could save ??

  9. Impact: costs • ‘Million dollar patients’ • 3,800 (approx) in USA in 2010 • Savings at most $3.8 billion?? vs • Reducing avoidable complications for people with chronic disease by 10% could save $40 billion

  10. Challenges • Patients • Medications, physical functioning • Concept of treatment burden • Healthcare providers • Lack of time • Uncertainty and poor evidence base

  11. Related issues • Overlap with frailty in older people • Link with socioeconomic deprivation • Men in most deprived group die 18 years earlier • Develop multimorbidity earlier • Inverse care law

  12. Multimorbidity • Vulnerable patients within this group • Multiple medicines • High risk emergency admission • High service use and costs • Lack social support • Need cost effective intervention to improve outcomes • How to identify those in need of intervention (before it is too late)?

  13. Research Programme

  14. Cochrane review • Qualitative study with GPs and pharmacists • Impact of multimorbidity: • Chronic respiratory disease • Diabetes • Exploratory trial 1 • Exploratory trial 2 • Proposed cohort study and RCT Preclinical phase: Theory Phase II: Exploratory trial Phase III: Definitive RCT Phase I: Modelling Continuum of increasing evidence

  15. Qualitative study of experiences’ of GPs and pharmacists managing multimorbidity • Focus groups with GPs and pharmacists • Themes • Link to multiple medicines and ageing • Health systems issues relating to lack to time, interprofessional communication difficulties, and fragmentation of care • Individual issues relating to professional roles, clinical uncertainty, and avoidance • Patient issues: ‘Not all need intervention’

  16. Qualitative study of experiences’ of GPs and pharmacists managing multimorbidity • Idea of ‘Pandora’s box’ • Limited time • Coping strategies “Like eating an elephant, bite off one chunk at a time”

  17. Cochrane review • Qualitative study with GPs and pharmacists • Impact of multimorbidity: • Chronic respiratory disease • Diabetes • Exploratory trial 1 • Exploratory trial 2 • Proposed cohort study and RCT Preclinical phase: Theory Phase II: Exploratory trial Phase III: Definitive RCT Phase I: Modelling Continuum of increasing evidence

  18. Impact on chronic disease: Chronic Respiratory Disease (CRD) • Cross sectional study in three Dublin general practices • Results • 16,946 patients in total and 3.9% CRD • 60% of these had multimorbidity • Multimorbidity associated with increasing age and low socio-economic status • Increased consultation rates and numbers medicines

  19. Impact on chronic disease: Diabetes • 424 patients with type 2 diabetes • Results • 90% two or more conditions • 25% had five or more chronic conditions • 189 conditions • Mismatch between self-report and chart review

  20. Cochrane review • Qualitative study with GPs and pharmacists • Impact of multimorbidity: • Chronic respiratory disease • Diabetes • Chronic ills of ageing • Exploratory trial 1 • Exploratory trial 2 • Proposed cohort study and RCT Preclinical phase: Theory Phase II: Exploratory trial Phase III: Definitive RCT Phase I: Modelling Continuum of increasing evidence

  21. Exploratory trial 1 • 20 patients with Chronic respiratory disease plus 2 other conditions; Age 40-75 • Intervention: 1. GP reports 2. Occupational therapy (OT) assessments and treatment if indicated

  22. Exploratory trial 1 • Results: • 8/20 needed OT • OT group had significant improvements but intervention intensive+ • High levels depression and anxiety • GP reports ineffective

  23. Exploratory trial 2 • 30 patients with 2 or more chronic conditions; >40, recruited prospectively by GP • Intervention • Six week, group based, OT-led with some physiotherapy and medicines management • Significant improvements in OT and psychosocial outcomes

  24. Exploratory trial 1 • Exploratory trial 2 • Cohort study and proposed RCT • Cochrane review • Qualitative exploration of views of GPs and pharmacists • Impact of multimorbidity in diabetes and chronic respiratory disease Preclinical phase: Theory Phase II: Exploratory trial Phase III: Definitive RCT Phase I: Modelling Continuum of increasing evidence

  25. Cohort study • 800 patient over aged 70 with focus on admissions • Identifying patients with multimorbidity at increased risk hospital admission • Risk score • Interviews with patients and their families who have experienced recent admission exploring triggers and potential preventable measures

  26. Proposed randomised controlled trial • Complex intervention to improve outcomes for vulnerable patients with multimorbidity • Participants • MM plus recent admission • Intervention: • OT groups, case management and medication review • Outcomes • Readmission, self-efficacy, quality of life

  27. Current HSE policy and multimorbidity? • Chronic disease management • Integrated care • Multidisciplinary care • Support for self-care Single conditions

  28. Policy choices • Support generalist approach • Medicines management • Focus on relevant interventions and outcomes • Target increased risk individuals • Identification and cost effective intervention • Reduce burden of care

  29. http://www.bmj.com/highwire/section-pdf/9015/7/1

  30. Summary • Multimorbidity important • International relevance • Link to quality of care and cost agenda • Challenges • Identifying individuals at increased risk • Delivering cost effective interventions http://www.healthtalkonline.org/

  31. Acknowledgment: All patients and practices who participated in research studies Questions?

  32. Additional material

  33. Exploratory trial 1 • Exploratory trial 2 • Proposed cohort study and RCT • Cochrane review • Qualitative study with GPs and pharmacists • Impact of multimorbidity: • Chronic respiratory disease • Diabetes Preclinical phase: Theory Phase II: Exploratory trial Phase III: Definitive RCT Phase I: Modelling Continuum of increasing evidence

  34. Cochrane review of interventions to improve outcomes for patients with multimorbidity • Ten studies; all recent randomised controlled trials • Eight included patients with a broad range of conditions though elderly; two focused on co-morbid conditions • Comparing outcomes across studies a problem • Identified types of interventions being tested

  35. Cochrane review: Interventions (all had multiple elements) • Professional • Education • Organisational • Care coordinators; changes to care delivery such as introduction new team member • Patient • Patient education or support groups, individual care plans • No financial or regulatory type interventions

  36. Cochrane review conclusions • Limited research to date • Focus on co-morbid conditions or multimorbidity in older patients • Results suggest may be more effective to target interventions towards risk factors or specific functional difficulties. Organisational models such as Guided Care disappointing

More Related